Alterity Therapeutics Ltd (ATHE) stock
ATHENasdaqPharmaceutical PreparationsFiscal year ends June 30Also trades as PRNAF
Số liệu tài chính tới năm tài chính 2026, năm kết thúc ngày Jun 30, 2026Last filing: 20-F on Aug 28, 2026Score 5/30
$1.70−0.17 (-8.85%)
Close on Nov 18, 2026Market cap $30.81MP/E –Yield –
Alterity Therapeutics cash
Cash and short-term investments held at the end of each period.
Alterity Therapeutics's cash was A$37.32M at Jun 30, 2026. For fiscal 2026 it was A$37.32M, up 12.5% from the year before. Over ten years it grew 2.7% a year on average. The highest annual figure on record is A$37.32M in fiscal 2026.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Jun 30, 2026 | A$37.32M | +12.5% |
| FY2025 | Jun 30, 2025 | A$33.16M | +162.4% |
| FY2024 | Jun 30, 2024 | A$12.64M | -19.9% |
| FY2023 | Jun 30, 2023 | A$15.77M | -54.7% |
| FY2022 | Jun 30, 2022 | A$34.81M | +23.8% |
| FY2021 | Jun 30, 2021 | A$28.12M | +205.7% |
| FY2020 | Jun 30, 2020 | A$9.20M | -36.1% |
| FY2019 | Jun 30, 2019 | A$14.40M | -5.5% |
| FY2018 | Jun 30, 2018 | A$15.24M | -30.4% |
| FY2017 | Jun 30, 2017 | A$21.88M | -23.5% |
| FY2016 | Jun 30, 2016 | A$28.59M | -18.1% |
| FY2015 | Jun 30, 2015 | A$34.91M | – |
Quarterly cash
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2026CQ2 2026 | Jun 30, 2026 | A$37.32M | +7.2% |
| Q4 FY2025CQ2 2025 | Jun 30, 2025 | A$33.16M | -10.4% |
| Q4 FY2024CQ2 2024 | Jun 30, 2024 | A$12.64M | -55.0% |
| Q4 FY2023CQ2 2023 | Jun 30, 2023 | A$15.77M | -55.0% |
| Q4 FY2022CQ2 2022 | Jun 30, 2022 | A$34.81M | +278.5% |
| Q2 FY2022CQ4 2021 | Dec 31, 2021 | A$37.00M | +203.8% |
| Q4 FY2021CQ2 2021 | Jun 30, 2021 | A$28.12M | +95.2% |
| Q2 FY2021CQ4 2020 | Dec 31, 2020 | A$35.04M | +130.0% |
| Q4 FY2020CQ2 2020 | Jun 30, 2020 | A$9.20M | -58.0% |
| Q2 FY2020CQ4 2019 | Dec 31, 2019 | A$12.18M | -57.4% |
| Q4 FY2019CQ2 2019 | Jun 30, 2019 | A$14.40M | -58.8% |
| Q4 FY2018CQ2 2018 | Jun 30, 2018 | A$15.24M | – |
| Q4 FY2017CQ2 2017 | Jun 30, 2017 | A$21.88M | – |
| Q4 FY2016CQ2 2016 | Jun 30, 2016 | A$28.59M | – |
| Q4 FY2015CQ2 2015 | Jun 30, 2015 | A$34.91M | – |
See a number that looks wrong?